Ebru Erbay, MD, PhD

Ebru Erbay received a PhD from University of Illinois at Urbana Champaign in 2004 and MD from Ankara University in 1998. She pursued a post-doctoral fellowship at Harvard School of Public Health to study the role of organelle stress in metabolic and inflammatory diseases. Dr. Erbay was a faculty member in Bilkent University from 2010 to 2017 and in Cedars-Sinai Medical Center and University of California in Los Angeles from 2017-2022 prior to becoming a founding principal investigator of Altos Labs. Currently, Dr. Erbay is a Cardiology faculty member in the University of California in Los Angeles.

By combining a deep interest in the molecular regulation of organelle stress with in vivo disease modeling, Dr. Erbay’s research strives to illuminate novel mechanisms that drive aging-associated, complex metabolic and inflammatory diseases such as atherosclerosis and metabolic dysfunction-associated steatotic liver disease. Dr. Erbay was a recipient of the Sabri Ulker International Science Award for her research in the field of immunometabolism. Her academic research has been continuously supported by funding from NIH, European Research Council Starting Grant and EMBO Installation Grant.